Gilead Surges To 3-Year High On Expectations For Speedy Coronavirus DrugInvestors Business Daily • 03/06/20
Are Options Traders Betting on a Big Move in Gilead (GILD) Stock?Zacks Investment Research • 03/04/20
Gilead Sciences Acquiring Cancer-Focused Biotech Forty Seven for $4.9 BillionThe Motley Fool • 03/02/20